Fungal Meningitis: Second Rhode Island Case Reported By Ronald J. Resmini, Esq.

Share Article

Rhode Island contributes two more victims to the nationwide fungal meningitis scare that has gripped much of the country due to tainted epidural steroid injections as reported by the Ronald J. Resmini Law Offices, LTD

The Rhode Island Department of Health has identified the state's second case of illness linked to the nationwide fungal meningitis outbreak. The case announced Thursday is a Lincoln, RI resident in her 60’s who received spinal injections at Ocean State Pain Management of Woonsocket on August 31st and September 21st, 2012. She is reportedly recovering from her infection.

The Department of Health said on Monday that another woman in her 40’s was hospitalized and is receiving treatment after receiving an injection at another Ocean State facility. Both facilities were previously identified as distribution points of the contaminated lots.

According to the U.S. Centers for Disease Control and Prevention, the number of cases has climbed to 377 in nineteen states. Another 14,000 people in 23 states are at risk after having received the potentially tainted doses from NECC of Framingham, MA. So far, Rhode Island has not had as large a number of cases as Michigan, Indiana and Tennessee.

Two Rhode Island facilities, Ocean State Pain Management of Woonsocket and New England Anesthesiology, which have offices in Warwick and East Greenwich, have received medication from New England Compounding Center of Framingham, Massachusetts. These lots have been linked to a multi-state outbreak of meningitis following epidural steroid injections.

According to the Rhode Island Department of Health, two hundred and sixty-six Rhode Island residents have received the medications that have been recalled. Attempts have been made to contact all identified as receiving the tainted lots. Anyone who has received treatments at any of these facilities over the past few months should contact their physician immediately. It should be noted that this form of meningitis is not contagious. Symptoms may include fever, headaches, sensitivity to light and symptoms suggestive of a stroke, such as slurred speech.

Additional lots of the medication, although not linked to the outbreak at this time, have also been recalled. Further news on Wednesday concerned Ameridose, a sister company of NECC, which announced a recall of all its products, many of which are used for intravenous drips or during surgery. Residents are advised to monitor the State Department of Health’s periodic updates at:

Anyone diagnosed with fungal meningitis related symptoms, should contact the Law Offices of Ronald J. Resmini, LTD. With office locations in Providence, RI and Seekonk, MA we are always close by and willing to help. #401-751-8855

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Christopher Angelini
Ronald J. Resmini Law Offices, LTD
Email >
Visit website